Resources for Food and Drug Administration (FDA)

Angiotech gets FDA clearance for dialysis catheter

www.thestar.com

Angiotech Pharmaceuticals Inc. (TSX: ANP) announced Wednesday it has received approval from the U.S. Food and Drug Administration to begin selling its Hemo-Stream chronic dialysis catheter.

Angiotech signed a deal in April with Rex Medical, which developed the device, granting the Vancouver-based company an exclusive licence to market and distribute the catheter worldwide.Dialysis catheters are used for short-term vascular access to provide hemodialysis patients with the dialysis they need.

The company said the catheter allows higher flow rates, reduced potential for air embolism or bleeding, decreased procedural steps and makes catheter placement easier.

View the Resource

Share or bookmarklet this web page at: